Telangana Bans Almont-Kid Syrup After CDSCO Alert: Stop Use Notice Issued
Telangana Issues 'Stop Use' Notice for Almont-Kid Syrup

In a significant move to safeguard public health, the Telangana state government has issued an urgent directive against the use of a specific children's medication. The state's Drugs Control Authority (DCA) has formally advised citizens to immediately cease using 'Almont-Kid Syrup' if they have it in their possession.

Immediate Action Following Central Alert

The directive from the Telangana DCA comes in response to an alert issued by the Central Drugs Standard Control Organisation (CDSCO). The national regulatory body flagged concerns regarding the syrup, prompting state authorities to take swift preventive action. The official notice was made public on 10 January 2026.

Official Advisory and Public Instructions

The DCA's statement was clear and emphatic. It strongly advised the public to stop using the mentioned syrup without delay. Furthermore, the authority instructed individuals or healthcare providers who have the product to report the matter to the nearest office of the Drugs Control Authority. This step is crucial for regulatory bodies to track the distribution and ensure the product is withdrawn from circulation effectively.

The advisory stated: "In light of the above, the public is hereby strongly advised to immediately stop the use of the above syrup, if in possession, and report the same to the nearest Drugs Control Authority without delay."

Broader Implications for Drug Safety

This incident highlights the active vigilance and coordinated response between central and state drug regulators in India. Such 'stop use' notices are critical public health tools to prevent potential harm while a detailed investigation is underway. The specific nature of the concern raised by the CDSCO was not detailed in the initial alert, but such actions are typically based on potential quality deviations, contamination risks, or other safety parameters that do not meet the required standards.

Parents and caregivers are urged to check their home medical supplies and consult with their pharmacists or doctors if they have recently administered this syrup. The authorities have underscored that public cooperation in reporting the product is essential for the success of this safety measure.